Search

Things are still great. The market indexes are either making new all-time highs or within a whisker of them. The uptrend continues ahead of what is sure to be a booming economy in the months ahead.

In this week’s Cabot Explorer issue, Novo Nordisk (NVO) stock surges on the back of positive data on its best-selling weight loss drug Wegovy, U.S.-China tensions rise again, and we add one of the signature growth stocks on the market to our portfolio. Enjoy!

This morning, the company reported third quarter earnings per share of $0.41 vs. the consensus estimate of $0.42 (August year-end), and revenue of $1.2 billion vs. the expected $1.29 billion.

Behavioral studies have shown that when we buy or sell a stock, these factors play a prominent role in our decision.

The big question on investors’ minds is if this tech stock retreat is a precursor to something larger or a “normal” correction in the context of a bull market.

There is a huge increase in uncertainty with the market near the high. Although stocks were mostly higher by midday on Monday, the situation in Iran adds another degree of risk.

The current situation makes this an even better time to sell covered calls on stocks near the recent high. After a huge YTD rally in several previously underperforming sectors, a few stocks are generating very high-priced call premiums. An unpredictable market with stocks near the high after the strongest rally in years is the ideal time to turn the recent market successes into high income.

The CBOE Volatility Index (VIX) soared to the highest level since last April. Iran has thrown everything into flux, at least for now.

Oil prices soared to nearly $120 per barrel as war in the Middle East is spreading with no immediate signs of letting up. Several stock markets around the world suffered steep losses in Monday’s trading. U.S. stock market indices started the week’s trading down sharply but recovered somewhat by midday on Monday.

Looking for a stock to feature in today’s Investment of the Week, I noticed that all my candidates had something in common: they were firmly in the “Mid-Cap” range of market capitalization. The range for a mid-cap varies by source, but usually includes companies valued between $1 billion and $10...